Abstract
Background
The purpose of this study was to determine whether micropore formation caused by application of an electric current can increase the influx of anticancer drugs across cancer cell membranes with a concomitant increase in dose intensity and, therefore, toxicity to cancer cells.
Methods
Two cell lines, GCIY and KATO III, both established from human gastric cancers, were used as target cells to assess the effects of combining electroporation and anticancer drug therapy. Results were measured as the proliferation of cells to 50% of the value in control mice (IC50).
Results
When GCIY cells were used as targets in vitro, the IC50 value for bleomycin was decreased significantly by the electroporation, to 10−4 of the dose for the chemotherapeutic agent alone, and the IC50 values of cisplatin and 5-fluorouracil were decreased to one tenth of their baseline values. In the case of KATO III cells, the IC50 value for bleomycin was reduced by 10−2, but that of cisplatin did not change. The IC50 value for doxorubicin did not change when GCIY cells, showing multidrug resistance, or when KATO III cells, lacking multidrug resistance, were subjected to electroporation. When GCIY cells were transplanted subcutaneously into nude mice, the resultant tumors decreased to a minimum size at 2 weeks after combined treatment with bleomycin and electroporation.
Conclusion
Electroporation seems to be a promising adjunct to cancer chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zimmermann U, Vienken J, Pilwat G. Development of drug carrier systems: electric field induced effects in cell membranes. J Electroanal Chem 1980;116:553–574.
Wong TK, Newmann E. Electric field mediated gene transfer. Biochem Biophis Res Commun 1982;107:584–587.
Belehrader J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumors in mice. Eur J Can 1991;27:73–76.
Chang DC, Reese TS. Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. Biophys J 1990;58:1–12.
Presse F, Quillet A, Fournigault C, Fewnteum J, Fradelizi D. An improved electrotransfection method using square shaped electric impulsions. Biochem Biophys Res Commun 1988;151:982–990.
Orlowski S, Belehrader J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988;37:4727–4733.
Belehrader J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM. Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 1991;27:73–76.
Hamada H, Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1986;83:7785–7789.
Mohammed AM, David WW. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in a strain of mice infected with mammary tumor virus. Cancer Res 1996;26:1787–1800.
Sowers AE. Mechanism of electroporation and electrofusion. In: Chang et al. (eds) Guide to electroporation and electrofusion. San Diego; Academic Press 1992; 119.
Mir LM, Orlowski S, Belehrader J Jr, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68–72.
Shirakawa I, Azegami M, Isi S, Umezawa H. Reaction of bleomycin with DNA. Strand scission of DNA in the absence of sulfLydryl or peroxide compounds. J Antibiot 1971;24:761–766.
Umezawa H, Takeuchi T, Hori S, Sawa T, Ishuzuka, Ishikawa K, Komai T. Studies on the mechanism of antitumor effect of bleomycin on squamous cell carcinoma. J Antibiot 1972;25:409–420.
Andrews PA, Howell SB. Cisplatin uptake in human ovarian carcinoma cells. Proc Am Ass Can Res 1987;28:314–319.
Reed E. Cisplatin, Cancer Chemotherapy and Biological Response Modifiers. Annual 13 Pinedo H, Longo DL, Chabner BA (eds) Amsterdam; Elsevier, 1992:83–90.
Eastman A. Mechanism of resistance to cisplatin. In: Ozols RF (ed) Molecular and clinical advances in anticancer drug resistance. Boston; Kluwer Academic Publishers, 1991:233–249.
Higgins CF, Hiles ID, Salmond GP, Gill DR, Downie JA, Evans IJ, Holland IB, Gray L, Buckel SD, Bell AW, Mark AH. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 1986;323:448–450.
Chio KH, Chen CJ, Kriegler M, Roninson IB. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdrl (Pglycoprotein) gene. Cell 1988;53:519–529.
Author information
Authors and Affiliations
About this article
Cite this article
Kambe, M., Arita, D., Kikuchi, H. et al. Enhancement of the efficacy of anticancer drugs with electroporation: Successful electrochemotherapy against gastric cancer cell lines in vivo and in vitro. Int J Clin Oncol 2, 111–117 (1997). https://doi.org/10.1007/BF02488882
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02488882